Resource Tag: Prevention

  • Enhancing Collaboration Between Overdose Fatality Review (OFR) and CDR Teams

    This presentation provides a quick look of NFR-CRS data on deaths due to opioids, an outline of OFR and CDR shared processes, and an overview of each distinct program illustrating opportunities for collaboration while acknowledging unique processes.

    Webinar (passcode: NCFRP)
    Slides (PDF)
    OFR and CDR Collaboration (PDF)

  • Enhancing Fatality Review with Lessons from Brain Science

    This webinar focuses on incorporating Brain Science into all aspects of fatality review.

    Webinar (passcode: NCFRP)
    Slides (PDF)

  • COVID-19 and Pregnancy: A Look at Adverse Maternal and Neonatal Outcomes

    SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19), has been associated with significant maternal morbidity and poor neonatal outcomes, including preterm birth and stillbirth. Fatality review teams are collecting and analyzing information on cases of fetal, infant, and child deaths that are directly attributed to COVID-19, and those that are indirectly impacted by the pandemic. Learn from expert speakers the latest information on prevalence, risk factors, and the most current guidelines for medical/obstetric care and preventive strategies for pregnant patients with COVID-19.

    Webinar (passcode: NCFRP)
    Slides (PDF)

    Other Resources:
    COVID and Pregnancy Report (PDF)
    CDC Infographic on COVID-19 and Pregnancy (PDF)
    Resources: COVID-19 Vaccination in Pregnancy (PDF)

  • FIMR Meet Up 10/13/2021

    On October 13, 2021, the Center hosted an all-teams FIMR Meet Up. The following three webinars were recorded as part of the half-day virtual meeting.

    Powerful Stories, Purposeful Storytelling (passcode NCFRP)
    Breaking Cultural Barriers in Maternal Mental Health (passcode NCFRP)
    Using FIMR Data to understand and respond to disparities (passcode NCFRP)

  • Improving Our Understanding of Infants with Substance Exposure and Neonatal Abstinence Syndrome (NAS)

    What is the difference is between an infant born substance exposed and an infant born with neonatal abstinence syndrome (NAS)? Dr. Nancy K. Young answers this and other questions covering opioid use disorders; substance use during pregnancy; the difference between NAS and substance exposure; best practices for collaboration and plans of safe care; and suggestions for what fatality review teams can do to address the needs of families affected by substance use disorders.

    Webinar (passcode: NAS)
    Slides (PDF)
    Questions and Answers (PDF)

  • Review of Infant Deaths due to Congenital Anomalies

    This presentation will discuss the most common congenital anomalies, steps for evaluation and prevention of possible anomalies, and tips for effective review including family history, chart review, and risk of recurrence.

    Webinar (passcode: NCFRP)
    Slides (PDF)
    Q&A (PDF)

  • Pediatricians and Fatality Review Teams: Partnering for Prevention

    This presentation provides an overview of a unique funding opportunity regarding SUID prevention. This opportunity is provided through a partnership between the National Center and the AAP, with a goal of enhancing collaboration between AAP chapters and CDR teams.

    Webinar (passcode: NCFRP)
    Slides (PDF)

  • Safe Sleep: Partnering with Treatment Providers

    This webinar focuses on the current state of sudden unexpected infant death with an emphasis on drivers of decision-making regarding infant sleep practices among mothers with opioid use disorder. Additionally, resources to promote safe infant sleep are shared.

    Webinar (passcode: NCFRP)
    Slides (PDF)
    Resources (PDF)